The recent challenges in global distribution have highlighted the importance of securing essential medications like Ivermectin. Dependence on overseas producers exposes regions to potential vulnerabilities, including delivery delays, cost fluctuations, and even geopolitical risks. Moving towards domestic production of Ivermectin offers a multitude